UPG-83| CAS#| Novel potent antagonist| MedKoo

MedKoo Cat#: 208004 | Name: UPG-83

Description:

WARNING: This product is for research use only, not for human or veterinary use.

UPG-83 is a novel potent antagonist of the Urotensin-II (UT) Receptor

Chemical Structure

UPG-83

CAS#N/A

Theoretical Analysis

MedKoo Cat#: 208004

Name: UPG-83

CAS#: N/A

Chemical Formula: C53H67N11O11S2

Exact Mass: 1097.4463

Molecular Weight: 1098.31

Elemental Analysis: C, 57.96; H, 6.15; N, 14.03; O, 16.02; S, 5.84

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.

Bulk Inquiry

Related CAS #

No Data

Synonym

UPG-83; UPG83; UPG 83

IUPAC/Chemical Name

(S)-4-(((4R,7S,10S,13S,16S,19S)-13-((1H-indol-3-yl)methyl)-10-(4-aminobutyl)-16-benzyl-4-(((S)-1-carboxy-2-methylpropyl)carbamoyl)-7-(4-cyanobenzyl)-17,20,20-trimethyl-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-19-yl)amino)-3-amino-4-oxobutanoic acid

InChi Key

KNXNDPUPURVVGP-LBKVYCCMSA-N

InChi Code

InChI=1S/C54H69N11O11S2/c1-30(2)44(53(75)76)63-50(72)41-29-77-78-54(3,4)45(64-46(68)36(57)26-43(66)67)52(74)65(5)42(24-31-13-7-6-8-14-31)51(73)61-40(25-34-28-58-37-16-10-9-15-35(34)37)49(71)59-38(17-11-12-22-55)47(69)60-39(48(70)62-41)23-32-18-20-33(27-56)21-19-32/h6-10,13-16,18-21,28,30,36,38-42,44-45,58H,11-12,17,22-26,29,55,57H2,1-5H3,(H,59,71)(H,60,69)(H,61,73)(H,62,70)(H,63,72)(H,64,68)(H,66,67)(H,75,76)/t36-,38-,39-,40-,41-,42-,44-,45-/m0/s1

SMILES Code

O=C(N[C@@H](CC1=CNC2=C1C=CC=C2)C(N[C@H](C(N[C@H](C(N[C@@H](CSSC(C)([C@H](C(N3C)=O)NC([C@@H](N)CC(O)=O)=O)C)C(N[C@@H](C(C)C)C(O)=O)=O)=O)CC4=CC=C(C#N)C=C4)=O)CCCCN)=O)[C@@H]3CC5=CC=CC=C5

Appearance

Solid powder

Purity

>98% (or refer to the Certificate of Analysis)

Shipping Condition

Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition

Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility

To be determined

Shelf Life

>2 years if stored properly

Drug Formulation

To be determined

Stock Solution Storage

0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code

2934.99.9001

More Info

Instruction

View handling instruction

Preparing Stock Solutions

The following data is based on the product molecular weight 1,098.31 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
1 mM	1.15 mL	5.76 mL	11.51 mL
5 mM	0.23 mL	1.15 mL	2.3 mL
10 mM	0.12 mL	0.58 mL	1.15 mL
50 mM	0.02 mL	0.12 mL	0.23 mL

1. Carotenuto A, Auriemma L, Merlino F, Yousif AM, Marasco D, Limatola A, Campiglia P, Gomez-Monterrey I, Santicioli P, Meini S, Maggi CA, Novellino E, Grieco P. Lead optimization of P5U and urantide: discovery of novel potent ligands at the urotensin-II receptor. J Med Chem. 2014 Jul 24;57(14):5965-74. doi: 10.1021/jm500218x. Epub 2014 Jul 10. PMID: 24992374.